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Norepinephrine is required to promote
wakefulness and for hypocretin-induced
arousal in zebrafish
Chanpreet Singh†, Grigorios Oikonomou†, David A Prober*
Division of Biology and Biological Engineering, California Institute of Technology,
Pasadena, United States
Abstract Pharmacological studies in mammals suggest that norepinephrine (NE) plays an
important role in promoting arousal. However, the role of endogenous NE is unclear, with
contradicting reports concerning the sleep phenotypes of mice lacking NE due to mutation of
dopamine β-hydroxylase (dbh). To investigate NE function in an alternative vertebrate model, we
generated dbh mutant zebrafish. In contrast to mice, these animals exhibit dramatically increased
sleep. Surprisingly, despite an increase in sleep, dbh mutant zebrafish have a reduced arousal
threshold. These phenotypes are also observed in zebrafish treated with small molecules that inhibit
NE signaling, suggesting that they are caused by the lack of NE. Using genetic overexpression of
hypocretin (Hcrt) and optogenetic activation of hcrt-expressing neurons, we also find that NE is
important for Hcrt-induced arousal. These results establish a role for endogenous NE in promoting
arousal and indicate that NE is a critical downstream effector of Hcrt neurons.
DOI: 10.7554/eLife.07000.001
Introduction
Sleep remains among the most persistent and perplexing mysteries in modern biology. Several
studies have shown that neuronal centers that regulate sleep and wakefulness lie predominantly in the
hypothalamus and brainstem (Pace-Schott and Hobson, 2002; Saper et al., 2005), and many of the
neurotransmitters and neuropeptides employed by these centers are known. However, it remains
unclear how these centers interact with each other, and what specific functions are fulfilled by the
neurotransmitters and neuropeptides they employ. Norepinephrine (NE) is one of the most abundant
neurotransmitters in the central and peripheral nervous systems, and has been implicated in many
aspects of physiology and behavior, including cognition, attention, reward, locomotion and arousal
(Berridge and Waterhouse, 2003; Weinshenker and Schroeder, 2007; Sara, 2009). Small molecule
activators of NE signaling have been shown to increase wakefulness, whereas inhibitors promote sleep
(Berridge et al., 2012). These results suggest that NE plays a significant role in promoting arousal.
However, the role of endogenous NE in regulating the sleep/wake cycles of vertebrates remains
unclear, with contradicting reports concerning the sleep phenotype of mice that do not synthesize NE
due to mutation of dopamine beta hydroxylase (dbh) (Hunsley and Palmiter, 2003; Ouyang et al.,
2004).
The locus coeruleus (LC) in the brainstem is a major arousal promoting center and a major source of
NE in the brain (reviewed in Berridge and Waterhouse, 2003). Optogenetic studies in mice have
shown that activation of the LC promotes sleep-to-wake transitions, while inhibition of the LC reduces
time spent awake (Carter et al., 2010, 2012). These studies also showed that activation of the LC
plays an important role in mediating the arousing effects of hypocretin (hcrt)-expressing neurons
(Carter et al., 2010, 2012), which constitute an important arousal center in the hypothalamus
(Sutcliffe and de Lecea, 2002). These observations suggest that NE synthesized in the LC could be
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involved in mediating Hcrt-induced arousal. However, in addition to NE, the LC also produces other
neurotransmitters and neuropeptides that affect sleep, including dopamine (Dzirasa et al., 2006),
neuropeptide Y (Dyzma et al., 2010), neurotensin (Erwin and Radcliffe, 1993) and vasopressin (Born
et al., 1992). Manipulations of the LC likely affect the synaptic levels of these other neurotransmitters
and neuropeptides. Therefore, it is unclear whether NE is required to mediate the arousing effects of
LC neurons and Hcrt signaling, or if this is accomplished by another factor in LC neurons.
To address the role of NE in regulating vertebrate sleep/wake states, we generated dbh mutant
zebrafish that do not produce NE. Contrary to dbh null mice (Thomas et al., 1995), zebrafish dbh
mutants develop normally and are viable. Importantly, they also exhibit a dramatic increase in sleep.
Interestingly, despite increased sleep, these animals display a reduced arousal threshold. Using this
mutant, we show that NE is important for arousal that is induced by either genetic overexpression of
the Hcrt neuropeptide or optogenetic activation of Hcrt neurons. These results clarify the role of NE in
regulating vertebrate sleep and establish a role for NE in mediating Hcrt-induced wakefulness.
Results
Pharmacological inhibition of NE signaling increases sleep
Previous pharmacological studies in zebrafish (Rihel et al., 2010) suggested that the noradrenergic
system is an important regulator of sleep and wakefulness in zebrafish, similar to mammals (Berridge
et al., 2012). Therefore, we reasoned that the zebrafish model system could provide a new platform
for exploring the role of endogenous NE in sleep. Three classes of receptors mediate NE signaling:
the activating alpha1-and beta-adrenergic receptors and the inhibitory alpha2 adrenergic receptors.
For each class there exist at least 5 paralogs in the zebrafish genome, making pharmacological
manipulations more practical than genetic manipulations. We first tested the effects of prazosin,
eLife digest Although the neural circuits that regulate sleep and wakefulness have yet to be fully
identified, the importance of at least two brain regions is well established. These are the
hypothalamus, a structure deep within the brain that controls a number of basic activities including
hunger, thirst and sleep; and the brainstem, which connects the brain with the spinal cord.
Specific neurons within the hypothalamus and brainstem regulate the sleep–wake cycle by
signaling to one another using chemicals called neurotransmitters and neuropeptides. Throughout
the day, some hypothalamic neurons release a neuropeptide called hypocretin, which helps maintain
wakefulness. Hypocretin acts on neurons within the brainstem and causes them to release other
neurotransmitters that promote wakefulness. However, the identity of these molecules is unclear.
One candidate is norepinephrine. Drugs that enhance the effects of norepinephrine increase
wakefulness, whereas those that block norepinephrine signaling promote sleep. Despite this, mice
that have been genetically modified to lack the enzyme that produces norepinephrine exhibit
relatively normal sleep. This may be because in mammals, norepinephrine also has important roles
outside the brain, thus complicating the effects of this genetic modification on behavior.
Alternatively, while zebrafish that lack norepinephrine are healthy, mice containing this modification
die early in development. Treating these mice with a specific drug allows them to survive, but might
affect their behavior.
To clarify the role of norepinephrine and its interaction with hypocretin, Singh, Oikonomou and
Prober created a new animal model by genetically modifying zebrafish. In contrast to mice, zebrafish
that were unable to make norepinephrine slept more than normal fish, although they were also
lighter sleepers and were more prone to being startled. A genetic modification that increases
hypocretin signaling induces insomnia; Singh, Oikonomou and Prober found that this occurs only in
animals with normal levels of norepinephrine. Thus, these experiments indicate that hypocretin does
indeed promote wakefulness though norepinephrine.
The work of Singh, Oikonomou and Prober has clarified the role of norepinephrine in regulating
the sleep–wake cycle. These findings could help in the development of drugs that target the neurons
that make hypocretin, which may improve treatments for sleep disorders.
DOI: 10.7554/eLife.07000.002
Singh et al. eLife 2015;4:e07000. DOI: 10.7554/eLife.07000 2 of 22
Research article Neuroscience
a well-established alpha1-adrenergic receptor inhibitor, on zebrafish behavior. We found that,
compared to larvae exposed to dimethyl sulfoxide (DMSO) vehicle alone, larvae exposed to 100 μM
prazosin showed lower overall activity (Figure 1A,D) and activity when awake (Figure 1B,E) during
both day and night, as well as an increase in sleep during both day (+140%) and night (+60%)
(Figure 1C,F; Figure 1—figure supplement 1). This increase in sleep was primarily due to an increase
in the number of sleep bouts (+110% during the day and +70% during the night, Figure 1G), as well
as a smaller increase in sleep bout duration (+20% during the day) (Figure 1H). We also observed a
23% reduction in sleep latency at night in prazosin-treated animals (Figure 1I).
We further investigated whether treatment with the alpha2-adrenergic receptor agonist clonindine or
the beta1-adrenergic receptor antagonist bopindolol affects the sleep of larval zebrafish. We found
that the main effect of clonidine treatment was a reduction in day activity (−48%) and increase in day sleep
(+90%), with no effect in night activity or sleep (Figure 1—figure supplement 2), suggesting a day-specific
role for alpha2 receptors in sleep regulation. Bopindolol treatment resulted in reduction of night activity
(−40%) and increase in both day (+82%) and night (+60%) sleep (Figure 1—figure supplement 3).
dbh mutant larvae exhibit increased sleep
Encouraged by our pharmacological studies, we decided to investigate the role of endogenous NE in
sleep regulation using genetics. To this end we used the zinc-finger nuclease approach (Foley et al.,
2009), a well established technique in zebrafish that induces targeted mutations with few off-target
lesions (Doyon et al., 2008;Meng et al., 2008; Gupta et al., 2011), to generate zebrafish containing
a mutation in the single zebrafish dopamine beta-hydroxylase (dbh) gene (Chen et al., 2013a), which
encodes the enzyme that converts dopamine to NE. The dbhmutant allele that we generated contains
a four nucleotide insertion in the third exon, which gives rise to a premature stop codon, resulting in a
predicted 178 amino acid peptide lacking the DBH active site, instead of the full length 614 amino
acid protein (Figure 2—figure supplement 1A).
Although the murine dbh knockout (Thomas et al., 1995) displays no overt developmental defects,
only 10% of dbh−/− pups produced by dbh+/−mothers survive embryonic development and no dbh−/−
pups are born to dbh−/− mothers. In contrast to the mouse knockout, female dbh−/− zebrafish
produced a normal number of dbh−/− larvae when mated to dbh+/− males (out of 287 larvae
genotyped from 3 independent crosses, 49% were dbh+/− and 51% were dbh−/−). We verified that
dbh−/− larvae completely lack NE using an ELISA assay (Figure 2—figure supplement 1B). Using in
situ hybridization (ISH) we also found that the level of dbh mRNA in dbh−/− larvae is much lower than
in their dbh+/− siblings, presumably due to nonsense mediated decay of the mutant transcript (Isken
and Maquat, 2007) (Figure 2—figure supplement 1C). While only 40% of dbh mutant mice that
survive embryogenesis reach adulthood (Thomas et al., 1995), dbh−/− zebrafish embryos developed
to adulthood normally (24/96 (25%) of embryos produced by a male dbh+/− crossed to female dbh+/−,
and raised to adulthood, were identified as dbh−/−).
We used the dbh mutant to determine whether genetic ablation of NE affects the sleep/wake
patterns of zebrafish larvae. We observed that dbhmutants display lower overall activity (Figure 2A,D)
and activity when awake (Figure 2B,E) during both day and night. Importantly, we found that dbh−/−
larvae sleep much more during both day (+185%) and night (+57%) than sibling controls (Figure 2C,F).
During the day, the increase in sleep was due solely to more frequent sleep bouts (+220%), while
during the night both longer (+17%) and more frequent (+25%) sleep bouts occurred (Figure 2G,H).
Furthermore, sleep latency at night in the mutants was reduced by 40% (Figure 2I). It is interesting to
note that, as expected, treatment of dbh mutants with 100 μM prazosin did not affect sleep/wake
behavior compared to DMSO controls (Figure 2—figure supplement 2), suggesting that prazosin-
induced behavioral effects are specific to NE signaling.
dbh mutant larvae exhibit lower arousal threshold
Since dbh mutants exhibit increased sleep, we decided to investigate whether their arousal threshold
is also altered. To this end we delivered mechano-acoustic tapping stimuli of variable intensities to
larvae while monitoring their behavior using a videotracking system. We delivered a stimulus once a
minute during the night, and determined the fraction of larvae that responded to each stimulus.
This dataset allowed us to construct dose–response curves (Figure 3A) and calculate the tapping
intensity at which 50% of larvae responded to the stimulus (effective tap power 50, ETP50).
Surprisingly, the ETP50 for dbh−/− larvae was 2.1 compared to 3.1 for their dbh+/+ siblings
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(32% decrease) (p < 0.0001 by extra sum-of-squares F test), suggesting that although the dbhmutants
sleep more, they have a reduced arousal threshold. In addition to a lower ETP50, dbh−/− larvae also
exhibited an increased maximal response fraction, from 0.43 for dbh−/− compared to 0.34 for dbh+/+
(p < 0.0001 by extra sum-of-squares F test). Interestingly, treatment with the alpha1-adrenergic
Figure 1. Prazosin treated larvae are less active and sleep more than vehicle treated controls. Representative activity (A), waking activity (amount of
locomotor activity while awake) (B) and sleep (C) traces of vehicle (blue) and prazosin (red) treated zebrafish larvae. Bar graphs of activity (D), waking
activity (E), sleep (F), sleep bout number (G), sleep bout length (H) and sleep latency (I) from three combined experiments (n > 180 for each condition).
Bars represent mean ± s.e.m. *, p < 0.05 and ***, p < 0.0001 by one-way ANOVA.
DOI: 10.7554/eLife.07000.003
The following figure supplements are available for figure 1:
Figure supplement 1. Prazosin night sleep dose–response curve.
DOI: 10.7554/eLife.07000.004
Figure supplement 2. Clonidine treated larvae are less active and sleep more than vehicle treated controls during the day.
DOI: 10.7554/eLife.07000.005
Figure supplement 3. Bopindolol treated larvae sleep more than vehicle treated controls.
DOI: 10.7554/eLife.07000.006
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antagonist prazosin or the alpha2-adrenergic agonist clonidine did not affect the arousal threshold of
zebrafish larvae (data not shown). However, larvae treated with the alpha2-adrenergic antagonist
bopindolol showed a 54% decrease in their ETP50 from 5.7 to 2.6 (Figure 3B, p < 0.0001 by extra
Figure 2. dbh mutant larvae are less active and sleep more than sibling controls. Representative activity (A), waking activity (B) and sleep (C) traces of
dbh+/+ (blue) dbh+/− (cyan) and dbh−/− (red) zebrafish larvae. Bar graphs show mean ± s.e.m. activity (D), waking activity (E), sleep (F), sleep bout
number (G), sleep bout length (H) and sleep latency (I) from seven combined experiments (n > 250 for each genotype). n indicates number of larvae.
***, p < 0.0001 and ns, not significant by one-way ANOVA.
DOI: 10.7554/eLife.07000.007
The following figure supplements are available for figure 2:
Figure supplement 1. Verification of zebrafish dbh mutant.
DOI: 10.7554/eLife.07000.008
Figure supplement 2. Treatment of dbh−/− fish with prazosin does not alter sleep/wake behavior.
DOI: 10.7554/eLife.07000.009
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sum-of-squares F test). The maximal response
fraction was increased from 0.42 to 0.53 but this
change did not achieve statistical significance
(p = 0.08).
Hypocretin (hcrt) overexpression-
induced wakefulness requires NE
The Hcrt neuropeptide has been shown to
promote wakefulness and inhibit sleep in zebra-
fish larvae (Prober et al., 2006) and mammals
(reviewed in Alexandre et al., 2013; Sakurai,
2013), and stimulation of Hcrt neurons has been
shown to promote sleep to wake transitions in
mice (Adamantidis et al., 2007). Hcrt has been
proposed to promote wakefulness in part by
stimulating the noradrenergic LC based on
several lines of evidence. First, the LC is densely
innervated by Hcrt neurons in both zebrafish
(Prober et al., 2006) (Figure 4—figure
supplement 1A,B) and mammals (Peyron
et al., 1998; Chemelli et al., 1999; Date et al.,
1999; Horvath et al., 1999) and LC neurons
express the Hcrt receptor (Horvath et al., 1999;
Bourgin et al., 2000; Prober et al., 2006). It is
worth noting, however, that the medulla oblon-
gata is another source of NE in the brain, and it
also receives Hcrt projections in zebrafish
(Figure 4—figure supplement 1C) and mammals
(Ciriello et al., 2003; Zhang et al., 2004).
Second, application of Hcrt peptide depolarizes
LC neurons in brain slices (Hagan et al., 1999)
and in vivo (Bourgin et al., 2000). Third, acute
inhibition of LC neurons using halorhodopsin
inhibits the arousing effects of stimulating Hcrt
neurons (Carter et al., 2012). However, despite
the evidence that the LC mediates Hcrt-induced
arousal, it is unknown whether this process
requires NE.
The mammalian genome contains two hcrt
receptor (hcrtr) paralogs, both of which are
required for the increase in locomotor activity and decrease in sleep observed after injection of
Hcrt peptide (reviewed in Alexandre et al., 2013; Sakurai, 2013). To determine whether the single
zebrafish hcrtr ortholog is required for the Hcrt overexpression phenotype in zebrafish larvae,
we mated Tg(hsp:Hcrt) zebrafish to a previously described hcrtr mutant (Yokogawa et al., 2007). We
subjected the larval progeny to heat shock (HS) during the sixth day post fertilization (dpf) to induce
Hcrt overexpression (Prober et al., 2006). We then compared the amount of sleep on night 6 (post-
HS) to night 5 (pre-HS). We previously showed that Hcrt protein levels remain elevated for over 48 hr
after HS, with no detectable decrease during the first 24 hr after HS (Prober et al., 2006), so
overexpressed Hcrt protein should remain at high levels throughout the night following HS. hcrtr+/−
and hcrtr−/− larvae reacted similarly to the HS, with no significant difference in the amount of sleep
between the two genotypes (Figure 4—figure supplement 2A,B). Hcrt overexpression decreased the
sleep of Tg(hsp:Hcrt);hcrtr+/− larvae by 50% (Figure 4—figure supplement 2C,D), as previously
described for Tg(hsp:Hcrt);hcrtr+/+ larvae (Prober et al., 2006). However, no decrease in sleep was
observed in Tg(hsp:Hcrt);hcrtr−/− larvae following HS (Figure 4—figure supplement 2C,D). These
results indicate that the decrease in sleep following overexpression of Hcrt requires a functional hcrtr.
Figure 3. dbh mutants and bopindolol-treated WT
larave exhibit lower arousal threshold. Stimulus-
response curves generated by a tapping assay for
dbh−/− and sibling control larvae (A), and bopindolol
and DMSO treated WT larvae (B). Thirty trials were
performed at each stimulus intensity, with a 1 min inter-
trial interval. Each data point indicates mean ± s.e.m.
Stimulus-response curves were constructed using the
non-linear variable slope module in Prism and fitted
using ordinary least squares. Dashed lines mark the
ETP50 values for different genotypes and drug treat-
ments. dbh−/− have an ETP50 value of 2.1 vs 3.1 for
sibling controls (32% decrease, p < 0.0001 by extra sum-
of-squares F test) (A), and bopindolol treated animals
have an ETP50 value of 2.6 vs 5.7 for sibling controls (54%
decrease, p < 0.0001 by extra sum-of-squares F test) (B).
n indicates number of larvae.
DOI: 10.7554/eLife.07000.010
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To test the hypothesis that NE is required for Hcrt-induced wakefulness, we mated Tg(hsp:Hcrt)+/−;
dbh+/− fish to dbh−/− fish and heat-shocked the larval progeny during day 6. We first asked whether
the presence or absence of NE affects the response of larvae to HS. Larvae lacking the hsp:Hcrt
transgene were similarly affected by the HS independently of whether they produced NE or not (no
significant difference observed between dbh+/− and dbh−/− larvae, Figure 4A,B). We therefore
conclude that lack of NE does not affect the response of larvae to HS. We next asked whether NE is
required for Hcrt overexpression-induced arousal (Figure 4C,D). As expected, the amount of sleep
exhibited by Tg(hsp:Hcrt) larvae was reduced following Hcrt overexpression (Figure 4D). Specifically,
the sleep of Tg(hsp:Hcrt)+/−;dbh+/− larvae was reduced to 40% of the pre-HS value (Figure 4D).
However, the sleep of Tg(hsp:Hcrt)+/−;dbh−/− larvae was reduced to 75% of the pre-HS value
(Figure 4D). Thus, the majority of Hcrt-induced sleep loss is blocked in the absence of NE.
Importantly, treatment of Tg(hsp:Hcrt)+/− animals with prazosin similarly inhibits Hcrt overexpression-
induced arousal (Figure 4—figure supplement 3) suggesting that the dbh mutant phenotype is
indeed due to the blocking of noradrenergic signaling. We also confirmed that the suppressed effect
of Hcrt overexpression on sleep in dbh and hcrtr mutants is not due to an effect of the mutations on
Figure 4. Reduced sleep at night due to Hcrt overexpression is suppressed in dbhmutants. (A, C) Sleep traces from
a single representative experiment; yellow region indicates time of heat shock (HS) during day 6. (B, D) Bar graphs
show mean ± s.e.m. percentage change in sleep during night 6 compared to night 5 from four combined
experiments. (B) In the absence of the hsp:Hcrt transgene, HS during day 6 has no significant effect on dbh−/−
larvae compared to dbh+/− larvae. (D) The reduced sleep induced by Hcrt overexpression is significantly diminished
in dbh−/− larvae compared to dbh+/− sibling controls. n indicates number of larvae. ***, p < 0.0001 and ns, not
significant by one-way ANOVA.
DOI: 10.7554/eLife.07000.011
The following figure supplements are available for figure 4:
Figure supplement 1. Hcrt neurons project to dbh expressing cells.
DOI: 10.7554/eLife.07000.012
Figure supplement 2. Reduced sleep at night following Hcrt overexpression requires the hcrtr.
DOI: 10.7554/eLife.07000.013
Figure supplement 3. Reduced sleep at night due to Hcrt overexpression is suppressed by prazosin.
DOI: 10.7554/eLife.07000.014
Figure supplement 4. The heat shock promoter is not suppressed in hcrtr or dbh mutants.
DOI: 10.7554/eLife.07000.015
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the efficacy of the HS overexpression system (Figure 4—figure supplement 4). These results indicate
that NE plays an important role in Hcrt-mediated arousal, but suggest that Hcrt also inhibits sleep via
NE-independent mechanisms.
Activation of hcrt neurons using ChR2 increases locomotor activity
As an alternative approach to study the effects of activated Hcrt signaling on larval zebrafish behavior,
we generated transgenic zebrafish in which the hcrt promoter (Faraco et al., 2006) drives expression
of channelrhodopsin-2 fused to EYFP (hcrt:ChR2-EYFP). Using immunofluorescence, we verified that
ChR2-EYFP is exclusively expressed in Hcrt neurons, and that all Hcrt neurons express ChR2-EYFP
(Figure 5—figure supplement 1A). To test whether the hcrt:ChR2-EYFP transgene can activate Hcrt
neurons, we exposed larvae to blue light for 30 min, and then performed double fluorescent ISH using
probes specific for hcrt and c-fos. We observed that 40% of Hcrt neurons in Tg(hcrt:ChR2-EYFP) larvae
expressed c-fos, compared to only 5% of Hcrt neurons in control Tg(hcrt:EGFP) larvae (Figure 5A,B).
This result confirms that the light paradigm employed activates Hcrt neurons.
To test the behavioral effect of activating Hcrt neurons using ChR2, we developed a large-scale
and non-invasive optogenetic behavioral assay. We modified the locomotor activity assay by adding
an array of blue and red LEDs that uniformly illuminates the 96-well plate, thus allowing simultaneous
light stimulation of 96 freely behaving larvae. Larvae at 5 dpf were transferred to a 96-well plate and
kept in the dark for 8 hr in the behavioral chamber, after which they were exposed to either red or
blue light for 30 min. The behavior of Tg(hcrt:ChR2-EYFP) larvae was compared to their non-
transgenic siblings throughout the night with an inter-trial interval of 3 hr. A typical response to blue
or red light included a burst of activity at light onset lasting approximately 30 s, followed by a return to
near baseline activity levels, a gradual increase in activity that reached a plateau for the remainder of
the illumination phase, and a burst of activity when the lights were turned off. The bursts of activity
observed at light onset and offset were similar for transgenic and non-transgenic larvae and were
excluded from behavioral analysis. Tg(hcrt:ChR2-EYFP) larvae and their non-transgenic siblings
exhibited similar levels of locomotor activity when illuminated with red light (Figure 5C,D), a
treatment that does not activate ChR2. In contrast, when illuminated with blue light the total
locomotor activity of Tg(hcrt:ChR2-EYFP) larvae increased by 46% compared to non-transgenic
siblings (Figure 5E,F). Activation of Hcrt neurons by ChR2 also altered the dynamics of locomotor
activity. Specifically Tg(hcrt:ChR2-EYFP) larvae displayed a 25% increase in the maximum activity level
reached during stimulation (Figure 5—figure supplement 1B) and reached this maximum activity
level 20% faster (Figure 5—figure supplement 1C) than sibling controls.
We next asked whether the increase in locomotor activity observed upon activation of zebrafish
Hcrt neurons using ChR2 requires the hcrtr. We first confirmed that hcrtr−/− larvae in the absence of
the hcrt:ChR2-EYFP transgene respond to blue light in a manner similar to their hcrtr+/− and hcrtr+/+
siblings. Indeed, we observed no significant difference in the locomotor activity of larvae of the three
genotypes during exposure to blue light (Figure 6A,B). However, Tg(hcrt:ChR2-EYFP);hcrtr−/− larvae
were 25% less active than their Tg(hcrt:ChR2-EYFP);hcrtr+/− and Tg(hcrt:ChR2-EYFP);hcrtr+/+
siblings in response to blue light. This result indicates that a functional hcrtr is important for Hcrt
neuron-induced arousal (Figure 6C,D).
Mammalian and zebrafish Hcrt neurons coexpress other neurotransmitters and neuropeptides,
such as glutamate and dynorphin (Chou et al., 2001; Rosin et al., 2003; Appelbaum et al., 2009; Liu
et al., 2015), which could play a role in locomotor activity that is induced by stimulation of Hcrt
neurons. Determining whether this is the case requires directly comparing locomotor activity in hcrtr−/−
larvae with and without the hcrt:ChR2-EYFP transgene. Since these larvae were previously tested in
separate experiments, we repeated the experiment but included all six genotypes in the same
behavioral plates. As expected, blue light stimulation significantly increased locomotor activity for Tg
(hcrt:ChR2-EYFP);hcrtr+/+ compared to hcrtr+/+ larvae, and for Tg(hcrt:ChR2-EYFP);hcrtr+/−
compared to hcrtr+/− larvae (Figure 6—figure supplement 1). Tg(hcrt:ChR2-EYFP);hcrtr−/− were
also more active than hcrtr−/− larvae, although the difference was much smaller than for Tg(hcrt:
ChR2-EYFP);hcrtr+/+ compared to hcrtr+/+ larvae. Furthermore, Tg(hcrt:ChR2-EYFP);hcrtr+/+ larvae
were significantly more active than Tg(hcrt:ChR2-EYFP);hcrtr−/− larvae. These results suggest that
most, but not all, of the effect of stimulating Hcrt neurons on locomotor activity is due to Hcrt
signaling, similar to results obtained in mammals (Adamantidis et al., 2007).
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Thus, similar to Hcrt overexpression (Prober et al., 2006), optogenetic activation of only ∼8 larval
zebrafish Hcrt neurons (an average of 40% of the 20 Hcrt neurons are c-fos positive upon stimulation
with ChR2; Figure 5B) increases locomotor activity, consistent with a role for Hcrt neurons in
promoting arousal (Lee et al., 2005; Mileykovskiy et al., 2005; Adamantidis et al., 2007; Carter
et al., 2012). This effect appears to be significantly stronger than the phenotype described in mice
(Adamantidis et al., 2007; Carter et al., 2012), suggesting that zebrafish may be more sensitive to
the arousing effect of Hcrt. These experiments also demonstrate for the first time a large-scale and
non-invasive application of optogenetics to manipulate the activity of a small population of neurons
deep in the brain of freely behaving animals. This approach may be generally useful for studies of
neuronal circuit function in regulating vertebrate behaviors.
Figure 5. Optogenetic activation of Hcrt neurons increases locomotor activity. (A) Representative images of Hcrt neurons co-labeled with EYFP or EGFP
(green) and c-fos (red). Scale bar = 10 μm. (B) Mean ± s.e.m. percentage of EYFP- or EGFP-expressing neurons that also express c-fos in Tg(hcrt:EGFP) and
Tg(hcrt:ChR2-EYFP) larvae. (C) Representative locomotor activity trace during red light exposure. (D) Average locomotor activity relative to WT siblings
during red light exposure. Data is pooled from 3 experiments and is represented as mean ± s.e.m. (E) Representative locomotor activity trace during blue
light exposure. (F) Average locomotor activity relative to WT siblings during blue light exposure. Data is pooled from 4 experiments and is represented as
mean ± s.e.m. Red and blue boxes in (C) and (E) indicate periods of red and blue light illumination. ‘A’ is the maximum activity reached for larvae of a
particular genotype and ‘TA’ is the time taken to reach maximum activity A. n indicates number of larvae. ***, p < 0.0001 by one-way ANOVA.
DOI: 10.7554/eLife.07000.016
The following figure supplement is available for figure 5:
Figure supplement 1. Specific expression of ChR2-EYFP in Hcrt neurons and temporal dynamics of hcrt:ChR2-EYFP induced locomotor activity.
DOI: 10.7554/eLife.07000.017
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Optogenetic stimulation of hcrt neurons activates dbh-expressing LC
neurons
Based on our observation that larval zebrafish Hcrt neurons innervate the LC (Figure 4—figure
supplement 1) and previous studies in mammals and zebrafish (Peyron et al., 1998; Chemelli et al.,
1999; Date et al., 1999; Horvath et al., 1999; Kaslin et al., 2004; Prober et al., 2006), we sought to
explore the functional interaction between the two neuronal populations using a combination of
optogenetics and calcium imaging. Using a transient injection approach (see ‘Materials and
methods’), we generated Tg(hcrt:ChR2-EYFP) and Tg(hcrt:EGFP) larvae in which single LC neurons
expressed the genetically encoded calcium indicator GCaMP6s. After paralyzing and mounting these
larvae in low melt agarose, we illuminated with a 488 nm laser a region of the brain containing the Hcrt
neuron soma with 10 short pulses (0.3 s each over 3.2 s total), then imaged GCaMP6s fluorescence in
the LC for 30 s (Figure 7A). We reasoned that even though we did not stimulate Hcrt neurons and
image the LC simultaneously, the short time interval between the final stimulation pulse and the
initiation of imaging (<0.1 s), and the relatively slow kinetics of GCaMP6s fluorescence changes (Chen
et al., 2013b), would allow us to detect Hcrt neuron-induced effects on LC neuron activity. Indeed,
over multiple trials in several animals we observed a significant increase in GCaMP6s fluorescence in
Tg(hcrt:ChR2-EYFP) larvae, but not in Tg(hcrt:EGFP) larvae (Figure 7B–E, Videos 1 and 2), indicating
that stimulation of Hcrt neurons results in activation of the LC in zebrafish larvae.
NE is important for locomotor activity induced by optogenetic activation
of hcrt neurons
Optogenetic studies in rodents have shown that acute inhibition of LC neurons blocks the wake-
promoting effects of acute activation of Hcrt neurons (Carter et al., 2012). However, the contribution
Figure 6. The hcrtr is required for Hcrt neuron-induced increased locomotor activity. (A, C) Representative locomotor activity traces for hcrtr−/− and sibling
controls without (A) and with (C) the hcrt:ChR2-EYFP transgene during blue light exposure. (B, D) Average locomotor activity relative to sibling controls. Data
is pooled from 3 experiments in both cases. Data is represented as mean ± s.e.m. and is plotted as percentage of hcrtr+/+ (B) or hcrt:ChR2-EYFP; hcrtr+/+
(D). n indicates number of larvae. ***, p < 0.0001 and ns, not significant by one-way ANOVA followed by Tukey’s test to correct for multiple comparisons.
DOI: 10.7554/eLife.07000.018
The following figure supplement is available for figure 6:
Figure supplement 1. Hcrt signaling is required for Hcrt neuron-induced increased locomotor activity.
DOI: 10.7554/eLife.07000.019
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of NE to this phenotype is unclear. To test the hypothesis that NE is required for the arousing effect of
Hcrt neuron stimulation, we assayed the behavioral effects of optogenetically activated Hcrt neurons
in dbh−/− larvae (Figure 8). As we previously observed (Figure 2D,E), dbh−/− larvae were
significantly less active during the 30 min of baseline recording than sibling controls (dbh+/+ 31.0 ±
4.0, dbh+/− 39.7 ± 4.1 and dbh−/− 15.7 ± 2.6 s of activity, p < 0.05 by one-way ANOVA). dbh−/−
larvae were also 25% less responsive to blue light than both dbh+/+ and dbh+/− larvae (Figure 8A,B).
However, when Hcrt neurons were activated optogenetically the requirement for NE became more
pronounced, as the ChR2-induced increase in locomotor activity was reduced by 76% in Tg(hcrt:ChR2-
EYFP);dbh−/− larvae compared to both Tg(hcrt:ChR2-EYFP);dbh+/+ and Tg(hcrt:ChR2-EYFP);dbh+/−
siblings (Figure 8C,D). Thus, while it is possible that supranormal optogenetic activation of Hcrt
neurons could make NE more important for Hcrt-induced locomotor activity than it is under normal
conditions, these results suggest that NE is an important effector of Hcrt-neuron induced arousal.
Figure 7. Optogenetic stimulation of Hcrt neurons activates LC neurons. (A) Schematic representation of areas stimulated (Hcrt, yellow) and imaged (LC,
green). a = anterior, p = posterior. (B, C) Representative images of a LC cell expressing GCaMP6s in a Tg(hcrt:EGFP) (B) or Tg(hcrt:ChR2-EYFP) (C) larva
before (B, C) and immediately after (B′, C′) stimulation of Hcrt neuron region. (D) GCaMP6s fluorescence intensity for a representative LC neuron in a
Tg(hcrt:EGFP) (top) and a Tg(hcrt:ChR2-EYFP) (bottom) larva. Single-trial (gray) and average (black) responses are shown. (E) Mean ± s.e.m. ΔF/F (%) values
averaged for all trials. n indicates number of trials for 5 Tg(hcrt:EGFP) and 4 Tg(hcrt:ChR2-EYFP) larvae. ***, p < 0.001 by one-way ANOVA. See Videos 1
and 2 for examples of GCaMP6s imaging.
DOI: 10.7554/eLife.07000.020
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Discussion
The first catecholamine to be identified as a
neurotransmitter by Ulf von Euler in 1946, NE has
been implicated in many aspects of physiology
and behavior (Berridge and Waterhouse, 2003;
Weinshenker and Schroeder, 2007; Sara,
2009). Several lines of evidence indicate that
exogenous NE is a potent arousal-promoting
agent (reviewed in Berridge et al., 2012). In
Drosophila, lack of endogenous octopamine,
which is considered the invertebrate equivalent
of NE, results in increased sleep (Crocker and
Sehgal, 2008). However, the role of endogenous
NE in regulating vertebrate sleep remains
unclear.
The murine dbh knockout (Thomas et al.,
1995) displays no overt developmental defects.
However, only 10% of dbh−/− pups produced by
dbh+/− mothers survive embryonic development
and no dbh−/− pups are born to dbh−/−
mothers; all such embryos die by embryonic
day 13.5 (Thomas et al., 1995). Of the dbh−/−
pups that survive embryogenesis, only 40% reach adulthood. Although the basis of the embryonic
lethality is unclear, it was hypothesized to be due to abnormal heart development or function, as the
hearts of mutant embryos display greater heterogeneity in cell size and orientation (Thomas et al.,
1995). Supplementation of drinking water during gestation with dihydroxyphenylserine (DOPS), which
is converted to NE by L-aromatic-amino-acid decarboxylase (AADC), rescues the embryonic lethal
phenotype. Following birth, DOPS supplementation is not required for continued survival of dbh−/−
pups. Surprisingly, dbh−/− mice that reach adulthood were initially reported as having normal sleep/
wake cycles (Hunsley and Palmiter, 2003), although a later study reported a 20% increase in sleep
(Ouyang et al., 2004). These contradictory results could arise from differences in methodology, a
relatively subtle and thus poorly reproducible sleep phenotype, or the complication that mice lacking
dbh also exhibit higher levels of dopamine, the
substrate of DBH and a major neurotransmitter in
the brain.
In this study we sought to clarify the role of
endogenous NE in regulating vertebrate sleep
using pharmacology and genetics in zebrafish.
Sleep can be distinguished from inactivity using
electrophysiology or three behavioral criteria
(Campbell and Tobler, 1984; Borbely and
Tobler, 1996; Allada and Siegel, 2008). First,
sleep primarily occurs during specific periods of
the circadian cycle. Second, animals exhibit an
increased arousal threshold during sleep, al-
though they can still be aroused by strong
stimuli, thus distinguishing sleep from paralysis
or coma. Third, sleep is controlled by a homeo-
static system, which can be demonstrated as an
increased need for sleep following sleep depri-
vation. Based on these criteria, it has been shown
that rest in a variety of organisms, including
zebrafish (Zhdanova et al., 2001; Prober et al.,
2006; Yokogawa et al., 2007), meets the
behavioral definition of sleep. Several groups
Video 1. Pulsed illumination of hcrt:EGFP neurons
does not affect GCaMP6s fluorescence in LC neurons.
Two trials for a representative LC neuron are shown.
Frames labeled ‘Stimulation’ indicate periods during
which the soma of Hcrt neurons were illuminated by ten
0.3 s pulses of 488 nm light, during which time GCaMP6s
was not imaged in the LC. See Figure 7 for
quantification.
DOI: 10.7554/eLife.07000.021
Video 2. Pulsed illumination of hcrt:ChR2-EYFP neu-
rons increases GCaMP6s fluorescence in LC neurons.
Two trials for a representative LC neuron are shown.
Frames labeled ‘Stimulation’ indicate periods during
which the soma of Hcrt neurons were illuminated by ten
0.3 s pulses of 488 nm light, during which time GCaMP6s
was not imaged in the LC. See Figure 7 for
quantification.
DOI: 10.7554/eLife.07000.022
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have demonstrated behavioral, anatomical, genetic and pharmacological conservation of sleep
between zebrafish and mammals, establishing zebrafish as a simple vertebrate model for sleep
research (Zhdanova et al., 2001; Kaslin et al., 2004; Faraco et al., 2006; Prober et al., 2006; Renier
et al., 2007; Yokogawa et al., 2007; Rihel et al., 2010; Gandhi et al., 2015).
To study the function of NE in regulating zebrafish sleep, we generated a predicted null mutation
in the single zebrafish dbh ortholog (Figure 2—figure supplement 1). Unlike mice, dbh−/− zebrafish
larvae develop normally yet show reduced activity and strikingly increased sleep (+185% during the
day and +57% during the night) compared to sibling controls (Figure 2). Importantly, these
phenotypes were also observed in larvae treated with the alpha-adrenergic inhibitor prazosin
(Figure 1), which blocks NE signaling without affecting dopamine levels. This observation suggests
that the zebrafish dbh−/− phenotypes are due to lack of NE and not altered dopamine levels.
It is important to note that our pharmacological manipulations (blocking of the activating alpha1-
adrenergic receptors with the antagonist prazosin; activation of the inhibitory alpha2-adrenergic
receptors with the agonist clonidine; blocking of the activating alpha2-adrenergic receptors with the
antagonist bopindolol) did not fully recapitulate the activity and sleep phenotypes observed in the
dbh mutant. This is not surprising considering the inherent limitations of global exposure to a drug
and the fact that each receptor type has at least five paralogs in zebrafish that may have different
sensitivities to these drugs. Among these drugs, prazosin most faithfully phenocopied the dbh sleep/
wake phenotype (reduced day and night activity and increased day and night sleep) with differences
observed in sleep bout number. Clonidine reduced activity and increased sleep during the day, but
had almost no effect at night. Bopindolol increased sleep during the day and night, but only inhibited
activity at night. These observations suggest that alpha1-adrenergic receptors could be the main
facilitators of noradrenergic modulation of larval zebrafish sleep.
Why do dbh mutant mice fail to exhibit the robust sleep phenotypes observed in NE deficient
zebrafish? One possible explanation is that the chronic loss of NE in dbh mutant mice may induce
Figure 8. dbh is required for Hcrt neuron-induced increased locomotor activity. (A, C) Representative locomotor activity traces for dbh−/− and sibling
control larvae without (A) and with (C) the hcrt:ChR2-EYFP transgene during blue light exposure. (B, D) Average locomotor activity relative to sibling
controls. Data is pooled from 2 (B) or 3 (D) experiments. Data is represented as mean ± s.e.m. and is plotted as percentage of dbh+/+ (B) or hcrt:ChR2-
EYFP; dbh+/+ (D). n indicates number of larvae. *, p < 0.05 and ***, p < 0.0001 by one-way ANOVA followed by Tukey’s test to correct for multiple
comparisons.
DOI: 10.7554/eLife.07000.023
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compensatory mechanisms during development that do not occur in response to chronic loss of NE in
zebrafish. Another possibility is that DOPS treatment during gestation affects developmental
processes that ultimately affect behavior. An intriguing third potential explanation involves the role of
NE in the mammalian sympathetic nervous system in promoting brown adipose tissue (BAT)
thermogenesis (Cannon and Nedergaard, 2004). BAT thermogenesis has been shown to promote
slow wave sleep (Dewasmes et al., 2003) and to be required for sleep rebound after sleep
deprivation (Szentirmai and Kapas, 2014). Therefore, genetic ablation of dbh could induce two
competing effects. In the periphery, lack of NE reduces BAT thermogenesis and thus inhibits sleep. In
the central nervous system, lack of NE interferes with the normal arousal function of the LC and thus
inhibits wakefulness. The combination of these two opposing forces could result in a minor sleep
increase in dbh−/− mice, and the magnitude of this phenotype might be particularly sensitive to
experimental conditions. However, zebrafish larvae and flies do not regulate their body temperature
and are thus subject only to the sleep promoting effects of NE ablation, resulting in a dramatic
increase in sleep. It would be interesting to test whether mice in which dbh is deleted only centrally,
and thus have normal BAT thermogenesis in the periphery, display a similarly dramatic sleep increase.
To further characterize the dbh phenotype, we used an automated arousal threshold assay using a
mechano-acoustic stimulus. We were surprised to find that although dbh−/− larvae sleep more, they
display a lower arousal threshold (i.e. they respond to stimuli of lower intensity), as well as a higher
maximal response than sibling controls (Figure 3A). Genetic ablation of dbh is predicted to increase
dopamine levels in neurons that normally express dbh, since this enzyme converts dopamine to NE.
Indeed, dopamine levels are higher in dbh mutant mice compared to sibling controls (Thomas et al.,
1995). However, pharmacological inhibition of adrenergic receptors should not interfere with the
conversion of dopamine to NE. Interestingly, we were able to pharmacologically replicate the reduced
arousal phenotype seen in dbh−/− animals by treatment with bopindolol, a beta-adrenergic inhibitor,
but not with the alpha1-adrenergic inhibitor prazosin, or the alpha2-adrenergic agonist clonidine. The
ability of bopindolol to recapitulate the reduction in arousal threshold seen in the dbh mutant suggests
that this aspect of the mutant phenotype is a consequence of the silencing of beta-adrenergic receptor
signaling. Furthermore, the inability of prazosin (which increases sleep during day and night) or clonidine
(which increases sleep during the day) to recapitulate the phenotype suggests that the observed
reduction in arousal threshold is not simply a consequence of lighter sleep due to ‘over-sleeping’ in the
dbh mutant. These observations suggest that lack of beta-adrenergic receptor signaling potentiates
responses to sensory stimuli, and are particularly interesting considering that NE reuptake inhibitors
such as atomoxetine, which increase NE signaling, are used to treat patients suffering from Attention
Deficit/Hyperactivity Disorder (ADHD) (Garnock-Jones and Keating, 2009). It is important to note that
these pharmacological results do not preclude a role of excess dopamine release in the dbh mutant by
the previously noradrenergic neurons of the LC and/or medulla oblongata in reducing the arousal
threshold. This hypothesis is supported by zebrafish studies implicating dopamine in arousal modulation
(Burgess and Granato, 2007; Mu et al., 2012) as well as work demonstrating that dopaminergic
stimulation during anesthesia produces a robust arousal response (Taylor et al., 2013). Furthermore,
dopamine agonists have been shown to increase locomotion in zebrafish larvae (Rihel et al., 2010; Irons
et al., 2013) and dopamine promotes locomotor development in zebrafish larvae (Lambert et al., 2012).
The Hcrt neurons of the hypothalamus are a major arousal promoting center. Several lines of
evidence suggest that Hcrt promotes arousal, at least in part, via the LC. First, Hcrt neurons send
dense projections to the LC in rodents and zebrafish (Peyron et al., 1998; Chemelli et al., 1999; Date
et al., 1999; Horvath et al., 1999; Kaslin et al., 2004; Prober et al., 2006) (Figure 4—figure
supplement 1A,B). Second, the LC expresses the Hcrt receptor in rodents (Horvath et al., 1999;
Bourgin et al., 2000) and zebrafish (Prober et al., 2006). Third, application of Hcrt peptide
depolarizes LC neurons in brain slices (Hagan et al., 1999) and in vivo (Bourgin et al., 2000). Fourth,
optogenetic activation of Hcrt neurons induces c-Fos expression in the LC of mice (Carter et al.,
2012) and GCaMP6 activation in the LC of zebrafish larvae (Figure 7). Fifth, acute inhibition of LC
neurons blocks the effect of acute Hcrt neuron activation on sleep to wake transitions (Carter et al.,
2012). While these studies suggest that the LC plays an important role in mediating Hcrt-induced
arousal, it was unknown whether NE, a neurotransmitter in the LC, is required for this process. This
question is important because the LC produces other neurotransmitters and neuropeptides that have
been shown to affect sleep, including dopamine (Dzirasa et al., 2006), neuropeptide Y (Dyzma et al.,
2010), neurotensin (Erwin and Radcliffe, 1993) and vasopressin (Born et al., 1992).
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To address this question, we used two independent strategies to drive Hcrt-induced arousal. First,
we overexpressed Hcrt using a heat-shock inducible promoter, which was previously shown to
decrease sleep in zebrafish larvae (Prober et al., 2006). We observed that in the absence of NE, sleep
reduction was attenuated (Figure 4). Second, we developed a large-scale and non-invasive
optogenetic assay and used it to activate Hcrt neurons in freely behaving larvae (Figure 5). Similar
to Hcrt overexpression, activation of Hcrt neurons increased locomotor activity, consistent with the
increased sleep-to-wake transitions previously described in mammals (Adamantidis et al., 2007). This
observation provides evidence of a causal relationship between the activity of Hcrt neurons and
locomotor activity in zebrafish, and together with data from the mouse (Adamantidis et al., 2007)
supports an evolutionarily conserved role of Hcrt neurons in promoting arousal. We found that the
arousing effects of Hcrt overexpression (Figure 4) and Hcrt neuron activation (Figure 8) were
dramatically reduced in dbh mutant larvae, indicating that NE is an important downstream effector of
Hcrt-mediated arousal.
Interestingly, lack of NE did not completely abolish arousal induced by Hcrt overexpression
(Figure 4), suggesting that Hcrt also promotes arousal via NE-independent pathways. Whether these
pathways employ other molecules produced by the LC or are LC-independent remains to be tested.
Zebrafish Hcrt neurons also send projections to noradrenergic cells in the medulla oblongata, similar
to mammals (Ciriello et al., 2003; Zhang et al., 2004), suggesting that these cells might also mediate
Hcrt-induced arousal. Furthermore, in humans, Hcrt neurons are reciprocally connected to other
important arousal centers such as the cholinergic basal forebrain, the histaminergic tuberomammillary
nucleus, the dopaminergic ventral tegmental area and the serotonergic dorsal raphe (Alexandre
et al., 2013). Many of these connections are also present in zebrafish, with Hcrt neurons projecting to
dopaminergic, histaminergic and serotonergic populations (Panula et al., 2010). Although functional
interactions between Hcrt neurons and these populations have yet to be explored in zebrafish, the
anatomical and molecular similarities of zebrafish and mammalian brains suggest that at least a
portion of Hcrt-induced arousal is likely to be mediated by these centers.
In summary, we have demonstrated that endogenous NE is required to maintain normal levels of
wakefulness in a diurnal vertebrate. This study, together with previous reports in Drosophila (Crocker
and Sehgal, 2008) and mice (Ouyang et al., 2004), support a phylogenetically conserved role for
endogenous NE in promoting wakefulness. Furthermore, we showed that NE also plays an important
role in mediating arousal induced by either overexpression of the Hcrt peptide or activation of Hcrt
neurons. Finally, we established and characterized the zebrafish dbhmutant, a useful tool for studying
other processes that are thought to involve NE, including the fight-or-flight response (Colwill and
Creton, 2011), congestive heart failure (Thomas and Marks, 1978), cognitive disorders such as
Alzheimer’s (Chalermpalanupap et al., 2013) and Parkinson’s diseases (Rommelfanger et al., 2007),
and neuropsychiatric disorders including depression and ADHD (Chamberlain and Robbins, 2013).
Materials and methods
Ethics statement
All experiments followed standard protocols (Westerfield, 2000) in accordance with the California
Institute of Technology Institutional Animal Care and Use Committee guidelines (animal protocol
1580).
Transgenic and mutant zebrafish
Tg(hcrt:ChR2(H134R)-EYFP
A 1 kilobase (kb) genomic fragment upstream of zebrafish hcrt, described previously (Faraco et al.,
2006), was amplified using the primers 5′-ATAATAAATAAATCTGATGGGGTTTT-3′ and 5′-GAGTT-
TAGCTTCTGTCCCCTG-3′, and subcloned 5′ to a transgene encoding the H134R variant of
channelrhodopsin-2 (ChR2) fused to EYFP (Nagel et al., 2005; Lin et al., 2009), in a plasmid
containing Tol2 transposase recognition sequences. This plasmid was co-injected with Tol2
transposase mRNA to generate Tg(hcrt:ChR2-EYFP) stable transgenic lines. Screening for EYFP
expression identified several stable lines, two of which were used for experiments. Both lines
expressed EYFP specifically in Hcrt neurons. One line had a single insertion of the transgene and
exhibited weak EYFP fluorescence. For the experiment described in Figure 5, animals heterozygous
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for the transgene were incrossed to compare sibling larvae exhibiting no EYFP (wild-type) and moderate
EYFP (homozygous transgenic) fluorescence. Stimulation of Hcrt neurons using ChR2 had a much
stronger effect on locomotor activity in homozygous transgenic animals compared to heterozygotes.
We did not use this line in combination with hcrtr and dbhmutants in the same experiment because the
number of larvae of each genotype from a mating was too low to obtain robust data. The second line
contained multiple insertions of the transgene and outcrossing these fish produced larvae with EYFP
fluorescence intensities ranging from weak to strong. We used this line for experiments that required
outcrossing to hcrtr or dbh mutants in order to obtain larvae with strong ChR2 expression. Adults from
this line were mated with hcrtr or dbhmutants, and larvae with strong EYFP fluorescence were raised to
adulthood. These heterozygous mutants were then incrossed to generate larvae for behavioral
experiments. All larvae expressed ChR2-EYFP with varying fluorescent intensities due to multiple
insertions of the transgene. At the end of each behavioral experiment, EYFP fluorescence was visualized
and only larvae with bright fluorescence were used for analysis. To determine the effect of blue light
stimulation on hcrtr or dbh mutants without the ChR2-EYFP transgene, heterozygous mutant fish were
incrossed to obtain homozygous mutant, heterozygous mutant and wild type sibling larvae.
For Hcrt overexpression experiments, fish heterozygous for the hsp:Hcrt transgene and for the
hcrtr or dbh mutation were mated to fish that were homozygous for the hcrtr or dbh mutation. The
behavior of larvae with or without the hsp:Hcrt transgene was then compared in heterozygous and
homozygous mutants. This mating scheme was used to ensure that each experiment had enough
larvae of each genotype to obtain robust data. The hcrtrmutant (Yokogawa et al., 2007), dbhmutant
(Chen et al., 2013a), Tg(dbh:EGFP) transgenic line (Liu et al., 2015), Tg(hcrt:RFP) transgenic line
(Liu et al., 2015) and Tg(hsp:Hcrt) transgenic line (Prober et al., 2006) have previously been
described. Tg(hsp:Hcrt) fish were genotyped using the primers 5′-CGGGACCACCATGGACT-3′ and
5′-GGTTTGTCCAAACTCATCAATGT-3′, which generate a 470 bp band. dbh mutant fish were
genotyped using the primers 5′-GAGCTCATGCAACGAAC-3′, 5′-GTAAAACTCAACTGTTTACC
TAAAG-3′ and 5′-GTGCGTACATCTTTCGGG -3′, which generate 1 band for wild type (198 bp),
two bands for homozygous mutant (113 bp and 202 bp) and three bands for heterozygous mutant
(113 bp, 198 bp and 202 bp). hcrtr mutant fish were genotyped using the primers 5′-CCACC
CGCTAAAATTCAAAAGCACTGCTAAC-3′ and 5′-CATCACAGACGGTGAACAGG-3′, which generate
a 170 bp product that is cut by DdeI (New England Biolabs, Ipswich, MA, United States) in the mutant
to produce 140 and 30 bp bands. We outcrossed the dbhmutant to the parental TLAB wild type strain
three times to reduce the possibility of unlinked mutations, and we did not observe developmental
defects that can be indicative of such mutations. During the course of routine genotyping by fin
clipping, we found that adult dbh−/− fish often die following anesthesia with tricaine (E10521,
Sigma-Aldrich, St. Louis, MO, United States) at a commonly used dose (0.16 mg/ml). A lower
concentration of tricaine (0.08 mg/ml) allowed survival of dbh−/− fish. Furthermore, dbh−/− fish
sometimes died during or shortly after mating, perhaps due to a heightened sensitivity to stress.
dbh−/− larvae respond normally to sensory stimuli such as gentle poking.
Sleep/wake analysis
Sleep/wake analysis was performed as previously described (Prober et al., 2006). Larvae were raised
on a 14/10 hr light/dark (LD) cycle at 28.5˚C with lights on at 9 am and off at 11 pm. Dim white light
was used to raise larvae for optogenetic experiments to prevent stimulation of ChR2 by ambient light.
Individual larvae were placed into each well of a 96-well plate (7701-1651, Whatman, Pittsburgh, PA,
United States) containing 650 μl of E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2,
0.33 mM MgSO4, pH 7.4). Locomotor activity was monitored using a videotracking system (Viewpoint
Life Sciences, Lyon, France) with a Dinion one-third inch Monochrome camera (Dragonfly 2, Point
Grey, Richmond, Canada) fitted with a variable-focus megapixel lens (M5018-MP, Computar, Cary,
NC, United States) and infrared filter. The movement of each larva was recorded using the
quantization mode. The 96-well plate and camera were housed inside a custom-modified Zebrabox
(Viewpoint Life Sciences) that was continuously illuminated with infrared lights. The 96-well plate was
housed in a chamber filled with recirculating water to maintain a constant temperature of 28.5˚C. The
parameters used for movement detection were: detection threshold, 15; burst, 29; freeze, 3; bin size,
60 s. Data were analyzed using custom Perl and Matlab (Mathworks, Natick, MA, United States) scripts
(Source code 1), which conform to the open source definition.
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For Hcrt overexpression experiments, videotracker analysis was initiated at 4 dpf. During the afternoon
of 6 dpf, the 96-well plate was transferred to a 37˚C water bath for 1 hr to induce Hcrt overexpression. For
each larva, total sleep during night 6 was divided by the average total sleep on night 5 for all larvae of the
same genotype and converted to a percentage to compare among different genotypes.
Pharmacology
Prazosin hydrochloride (P7791, Sigma–Aldrich), clonidine hydrochloride (C7897, Sigma–Aldrich) and
bopindolol malonate (SC-200144, Santa Cruz Biotechnology, Dallas, TX, United States) were dissolved
in dimethyl sulfoxide (DMSO, 4948-02, Macron Chemicals, Center Valley, PA, United States) and
added to E3 medium for a final concentration of 0.1% DMSO and 100 μM prazosin, 5 μM clonidine or
20 μM bopindolol. At these concentrations, we observed robust behavioral phenotypes without
apparent toxicity or abnormal responses to a gentle stimulus. Controls were exposed to 0.1% DMSO
alone. For sleep/wake experiments drugs were added during the evening of the fourth day of
development and recording was performed from the beginning of day 5 until the end of night 6. For
arousal experiments, drugs were added in the afternoon of day 5, and experiments were performed
during night 5 (12:30 am to 7:30 am).
Analysis of dbh expression and NE levels
dbh ISH was performed using standard protocols (Thisse and Thisse, 2008) and developed using
nitro-blue tetrazolium and 5-bromo-4-chloro-3′-indolyphosphate (10760978103, Roche, Mannheim,
Germany). A fragment of the dbh gene was used as a probe (Guo et al., 1999). NE levels were
measured using an ELISA assay (17-NORHU-E01-RES, ALPCO, Salem, NH, United States) according to
the manufacturer’s instructions. Five larvae were analyzed per sample, with four samples analyzed in
triplicate for each genotype.
Arousal threshold assay
The videotracking system was modified by adding an Arduino (http://www.arduino.cc/) based
automated driver to control two solenoids (28P-I-12, Guardian Electric, Woodstock, IL, United States)
that delivered a tap to a 96-well plate containing larvae. This setup allowed us to drive the solenoids
with voltage ranging from 0 V to 20 V over a range of 4095 settings (from 0.01 to 40.95). In our
experiments we used taps ranging from a power setting of 1–36.31. Taps of 14 different intensities
were applied in a random order from 12:30 am to 7:30 am during the fifth night of development with
an inter-trial-interval of 1 min. Previous studies showed that a 15 s interval between repetitive stimuli is
sufficient to prevent behavioral habituation (Burgess and Granato, 2007; Woods et al., 2014). The
background probability of movement was calculated by identifying for each genotype the fraction of
larvae that moved 5 s prior to all stimuli delivered during an experiment (14 different tap powers x 30
trials per experiment = 420 data points per larva; average background movement). This value was
subtracted from the average response fraction value for each tap event (corrected response =
average response – average background movement). The response of larvae to the stimuli was
monitored using the videotracking software and was analyzed using Matlab (Mathworks) and Excel
(Microsoft, Redmond, WA, United States). Statistical analysis was performed using the Variable Slope
log(dose) response curve fitting module of Prism (Graphpad, La Jolla, CA, United States).
Immunofluorescence
Samples were fixed in 4% paraformaldehyde (PFA) in PBS overnight at 4˚C and then washed with
0.25% Triton X-100/PBS (PBTx). Brains were manually dissected and blocked for at least 1 hr in 2%
goat serum/2% DMSO/PBTx at room temperature or overnight at 4˚C. Antibody incubations were
performed in blocking solution overnight at 4˚C. Primary antibodies were rabbit anti-orexin A
(AB3704, 1:500; Millipore, Temecula, CA, United States), rabbit anti-RFP (632496, 1:100, Clontech,
Mountain View, CA, United States) and chicken anti-GFP (GFP-1020, 1:400, AvesLabs, Tigard, OR,
United States). Alexa Fluor secondary antibodies were used (1:500 for anti-orexin and anti-RFP
and 1:600 for anti-GFP, Life Technologies, Carlsbad, CA, United States). Samples were mounted in
50% glycerol/PBS and imaged using a Zeiss LSM 780 confocal microscope (Zeiss, Oberkochen,
Germany).
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ISH
To exclude the possibility that the HS promoter response is suppressed in hcrtr and dbh mutants, we
performed ISH to compare the level of overexpressed hcrt mRNA in hcrtr and dbh homozygous
mutants to their heterozygous mutant siblings. Fish heterozygous for the hsp:Hcrt transgene and for
the hcrtr or dbh mutation were mated to hcrtr or dbh homozygous mutants, respectively. Larvae from
these crosses were heat shocked during the afternoon at 6 dpf to induce hcrt overexpression, and
were fixed 30 min after HS in 4% PFA overnight at room temperature. ISH was performed using
digoxygenin (DIG) labeled antisense riboprobes (Thisse and Thisse, 2008). Images were acquired
using a Zeiss AxioImagerM1 microscope and samples were then genotyped by PCR.
Assay for activation of hcrt-expressing neurons by ChR2
Tg(hcrt:ChR2-EYFP) larvae were placed in a 96 well plate in the videotracking system as described
above, left in the dark for 8 hr, and then exposed to blue light for 30 min starting at 1 am. Larvae were
then fixed in 4% PFA overnight at 4˚C. Double-fluorescent ISH was performed using DIG- and 2,4-
dinitrophenol (DNP)-labeled riboprobes and the TSA Plus DNP System (NEL747A001 KT,
PerkinElmer, Waltham, MA, United States). Probes specific for c-fos and eyfp were used to quantify
the number of eyfp-expressing Hcrt neurons that expressed c-fos. Tg(hcrt:EGFP) larvae (Prober et al.,
2006) were used as negative controls. Samples were mounted in 50% glycerol/PBS and imaged using
a Zeiss 780 LSM confocal microscope.
Optogenetic behavioral assay and analysis
The videotracking system was modified to include a custom array containing three sets of red and blue
LEDs (627 nm, MR-D0040-10S and 470 nm, MR-B0040-10S, respectively, Luxeon V-star, Brantford,
Canada) mounted 15 cm above and 7 cm away from the center of the 96-well plate to ensure uniform
illumination. The LEDs were controlled using a custom built driver and software written in BASIC stamp
editor. A power meter (1098293, Laser-check, Santa Clara, CA, United States) was used before each
experiment to verify uniform light intensity (∼400 μW at the surface of the 96-well plate) and similar red
and blue light intensities were used. During the afternoon of the fifth day of development, single larvae
were placed into each well of a 96-well plate as described above and placed in the videotracker in the dark
for 8 hr. Larvae were then exposed to either red or blue light for 30 min, starting at 1 am. Three trials were
performed during the night, with an inter-trial interval of 3 hr. Total activity for each larva was monitored
for 30 min before and after light onset, with data collected in 10 s bins. Light onset caused a short burst of
locomotor activity lasting for ∼30 s for all genotypes, so data obtained during the minute before and after
light onset was excluded from analysis. A large burst of locomotor activity was also observed for all
genotypes when the lights were turned off after the 30 min illumination period. This data was excluded
from analysis and is not shown in the figures. The total amount of locomotor activity of each larva during
the 30 min of light exposure, excluding the minute after light onset, was divided by the average baseline
locomotor activity for all larvae of the same genotype. The baseline period was defined as 30 min before
light onset, excluding the minute before light onset. Data from multiple experiments were pooled and
converted to percentage of wild type larvae.
GCaMP6s imaging
A 1.1 kb genomic fragment upstream of the dbh gene was amplified using the primers 5′-
ACTTGAACCAGCGACCTTCT-3′ and 5′-GGTTTGAAGGCCTTTCTAAGTTTTT-3′ (Liu et al., 2015)
and cloned 5′ to a transgene encoding GCaMP6s (Chen et al., 2013b) in a plasmid containing Tol2
transposase recognition sequences. Either Tg(hcrt:ChR2-EYFP) or Tg(hcrt:EGFP) embryos were
injected at the 1–2 cell stage with a solution containing 50 ng/μl plasmid, 0.04% phenol red and 50 ng/μl
Tol2 transposase mRNA. This injection procedure resulted in GCaMP6s expression in no more than
1 LC neuron per animal. At 5 dpf, larvae were paralyzed by immersion in 1 mg/ml α-bungarotoxin
(2133, Tocris, Bristol, UK) dissolved in E3, embedded in 1% low melting agarose (EC-202, National
Diagnostics, Atlanta, GA, United States) and imaged using a 20× water immersion objective on a Zeiss
LSM 780 confocal microscope. To stimulate Hcrt neurons, a region of interest (ROI) that encompassed
the Hcrt neuron soma was illuminated using a 488 nm laser at 100% power. Ten pulses lasting 0.3 s
each were applied over 3.2 s using the bleaching function, and then a ROI encompassing a GCaMP6s-
expressing LC soma was imaged at 4 Hz for 30 s. The time between the final stimulation pulse and
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initiation of imaging was less than 0.1 s. This cycle of stimulation and imaging was repeated 8 times for
each GCaMP6s-expressing soma. A baseline of 60 s was recorded before the first stimulation. Movies
were processed using ImageJ (Schneider et al., 2012). The mean fluorescence of each LC neuron was
measured by drawing a ROI around the soma. Baseline fluorescence (Fo) for each trial was defined as 10
frames immediately preceding the stimulation, and 10 frames post stimulation (F) were used to
measure the total change in fluorescence (ΔF/Fo = (F−Fo)/ Fo).
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